Long-term intrathecal drug administration for chronic nonmalignant pain

Journal of Neurosurgical Anesthesiology

Volumn 24, Issue 1, 2012, Pages 63-70

  Duarte, Rui V ^a,b   Raphael, Jon H ^a,b   Sparkes, Elizabeth ^a,c   Southall, Jane L ^b   Le Marchand, Karen ^b   Ashford, Robert L ^a  

^a BIRMINGHAM CITY UNIVERSITY   (United Kingdom)

^b RUSSELLS HALL HOSPITAL   (United Kingdom)

^c Institute for Clean Growth and Future Mobility   (United Kingdom)

Author keywords

Chronic nonmalignant pain; Intrathecal drug delivery systems; Prospective long term follow up; Sensory and psychosocial variables

Indexed keywords

BACLOFEN; BUPIVACAINE; CLONIDINE; DIAMORPHINE; MORPHINE; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; COPING BEHAVIOR; DEPRESSION; DIZZINESS; DRUG DELIVERY SYSTEM; DRUG IMPLANT; FEMALE; HUMAN; INFUSION PUMP; INTRACTABLE PAIN; LIBIDO DISORDER; LONG TERM CARE; MALE; NAUSEA; NONMALIGNANT PAIN; PAIN ASSESSMENT; PATIENT MOBILITY; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATION DEPRESSION; SELF CONCEPT; SLEEP; SOCIAL LIFE; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; VOMITING; WORK CAPACITY; WORK RESUMPTION;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ANALGESICS, OPIOID; CHRONIC PAIN; COHORT STUDIES; DEPENDENCY (PSYCHOLOGY); DEPRESSION; DRUG DELIVERY SYSTEMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MORPHINE; PAIN MEASUREMENT; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL BEHAVIOR; TREATMENT OUTCOME;

EID: 84857059664     PISSN: 08984921     EISSN: 15371921     Source Type: Journal    
DOI: 10.1097/ANA.0b013e31822ff779     Document Type: Article

References (47)

1. International Association for the Study of Pain. Pain terms: a list with definitions and notes on usage. Recommended by the IASP Subcommittee on Taxonomy. Pain. 1979;6:249-252.
2. World Health Organization. Cancer Pain Relief: With a Guide to Opioid Availability. Geneva: World Health Organization; 1996.
3. Onofrio BM, Yaksh TL, Arnold PG. Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc. 1981;56:516-520. (Pubitemid 11023593)
4. Mueller-Schwefe G, Hassenbusch SJ, Reig E. Cost effectiveness of intrathecal therapy for pain. Neuromodulation. 1999;2:77-87.
5. North RB, Cutchis PN, Epstein JA, et al. Spinal cord compression complicating subarachnoid infusion of morphine: case report and laboratory experience. Neurosurgery. 1991;29:778-784.
6. Coombs DW, Saunders RL, Gaylor MS, et al. Relief of continuous chronic pain by intraspinal narcotics infusion via an implanted reservoir. JAMA. 1983;250:2336-2339. (Pubitemid 13019248)
7. de Lissovoy G, Brown RE, Halpern M, et al. Cost-effectiveness of long-term intrathecal morphine therapy for pain associated with failed back surgery syndrome. Clin Ther. 1997;19:96-112. (Pubitemid 27186442)
8. Hassenbusch SJ, Paice JA, Patt RB, et al. Clinical realities and economic considerations: economics of intrathecal therapy. J Pain Symptom Manage. 1997;14(3 Suppl):S36-S48. (Pubitemid 27377606)
9. Deer TR, Smith HS, Cousins M, et al. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Pain Physician. 2010;13: E175-E213.
10. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. Surg Neurol. 2001;55:79-86. (Pubitemid 32297679)
11. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;1:CD006605.
12. Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery. 1999;44:289-300; discussion 300-301.
13. Patel VB, Manchikanti L, Singh V, et al. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician. 2009;12:345-360.
14. Atli A, Theodore BR, Turk DC, et al. Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up. Pain Med. 2010;11:1010-1016.
15. Hassenbusch SJ, Stanton-Hicks M, Covington EC, et al. Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage. 1995;10:527-543.
16. Turner JA, Sears JM, Loeser JD. Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systematic review of effectiveness and complications. Clin J Pain. 2007;23: 180-195. (Pubitemid 46145465)
17. Wallace M, Yaksh TL. Long-term spinal analgesic delivery: a review of the preclinical and clinical literature. Reg Anesth Pain Med. 2000;25:117-157. (Pubitemid 30161444)
18. Deer T, Winkelmü ller W, Erdine S, et al. Intrathecal therapy for cancer and nonmalignant pain: patient selection and patient management. Neuromodulation. 1999;2:55-66. (Pubitemid 29268513)
19. Raphael JH, Southall JL, Gnanadurai TV, et al. Long-term experience with implanted intrathecal drug administration systems for failed back syndrome and chronic mechanical low back pain. BMC Musculoskelet Disord. 2002;3:17.
20. Torrance N, Elliott AM, Lee AJ, et al. Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study. Eur J Pain. 2010;14:380-386.
21. Coffey RJ, Owens ML, Broste SK, et al. Medical practice perspective: identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer pain. Pain Med. 2010;11:1001-1009.
22. Chapman CR, Lipschitz DL, Angst MS, et al. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain. 2010;11: 807-829.
23. Morley S. Vivid memory for "everyday" pains. Pain. 1993;55: 55-62.
24. Salovey P, Smith A, Turk D, et al. The accuracy of memory for pain: not so bad most of the time. APS J. 1993;2:184-191. (Pubitemid 23274235)
25. Dawson EG, Kanim LE, Sra P, et al. Low back pain recollection versus concurrent accounts: outcomes analysis. Spine. 2002;27: 984-993; discussion 994. (Pubitemid 34506676)
26. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129-138.
27. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9-19. (Pubitemid 40038441)
28. Farrar JT, Young JP, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149-158. (Pubitemid 33016608)
29. Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9: 105-121. (Pubitemid 351147828)
30. Moore RA, Eccleston C, Derry S, et al. "Evidence" in chronic pain-establishing best practice in the reporting of systematic reviews. Pain. 2010;150:386-389.
31. Deer T, Krames ES, Hassenbusch S, et al. Management of intrathecal catheter-tip inflammatory masses: an updated 2007 consensus statement from an expert panel. Neuromodulation. 2008;11:77-91. (Pubitemid 351490209)
32. Winkelmü ller M, Winkelmü ller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg. 1996;85:458-467. (Pubitemid 26278029)
33. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage. 1996;11:71-80. (Pubitemid 26073492)
34. ThimineurMA, Kravitz E, Vodapally MS. Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study. Pain. 2004;109:242-249. (Pubitemid 38638700)
35. Chaney M. Side effects of intrathecal and epidural opioids. Can J Anaesth. 1995;42:891-903.
36. Ruan X. Drug-related side effects of long-term intrathecal morphine therapy. Pain Physician. 2007;10:357-366.
37. Doleys D, Dinoff B, Page L, et al. Sexual dysfunction and other side effects of intraspinal opiate use in the management of chronic noncancer pain. Am J Pain Manage. 1998;8:5-11. (Pubitemid 128167000)
38. Katz N, Mazer NA. The impact of opioids on the endocrine system. Clin J Pain. 2009;25:170-175.
39. Abs R, Verhelst J, Maeyaert J, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab. 2000;85:2215-2222. (Pubitemid 32269246)
40. Duarte RV, Raphael JH, Southall JL, et al. Intrathecal inflammatory masses: is the yearly opioid dose increase an early indicator? Neuromodulation. 2010;13:109-113.
41. Van Dongen RT, Crul BJ, De Bock M. Long-term intrathecal infusion of morphine and morphine/bupivacaine mixtures in the treatment of cancer pain: a retrospective analysis of 51 cases. Pain. 1993;55:119-123. (Pubitemid 23300823)
42. Sjöberg M, Nitescu P, Appelgren L, et al. Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine: bupivacaine dose regimen of 0.5:4.75 mg/mL. Anesthesiology. 1994;80:284-297. (Pubitemid 24064031)
43. Cabbell KL, Taren JA, Sagher O. Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report. Neurosurgery. 1998;42:1176-1180.
44. Bennett G, Serafini M, Burchiel K, et al. Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manage. 2000;20:S12-S36.
45. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006;104:570-587.
46. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain. 2008;24:479-496.
47. Bejjani GK, Karim NO, Tzortzidis F. Intrathecal granuloma after implantation of a morphine pump: case report and review of the literature. Surg Neurol. 1997;48:288-291. (Pubitemid 27377380)